EUVIMEDEUVIMED entdecken
Crossref

Urinary cell-free DNA as a noninvasive liquid biopsy for hepatocellular carcinoma

Amy K Kim, Selena Y Lin, Hsin-Ni Liu, Surbhi Jain, Terence P Gade, Fwu-Shan Shieh, James Hamilton, Hie-Won Hann, Ting-Tsung Chang, Dmitry Goryunov, Zhili Wang, Ying-Hsiu Su

World Journal of Gastroenterology · 07.09.2026 · 32 (33)

DOI: 10.3748/wjg.118587 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Gastroenterology, online erschienen am 07.09.2026. Verfasst von Amy K Kim und 11 weiteren Autor:innen. Die Arbeit nennt 38 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Cell-free DNA (cfDNA) has advanced cancer genetic profiling through liquid biopsy. Recent evidence suggests that urinary cfDNA may serve as a noninvasive alternative to plasma-derived cfDNA. AIM To comprehensively characterize transrenal DNA as a source for genetic profiling of hepatocellular carcinoma (HCC), using hepatitis B virus (HBV) DNA as a representative marker. METHODS HBV- and HCC-targeted next-generation sequencing (NGS) was performed to compare HBV fragment size distributions, 5’ 4-mer end motifs, and HCC mutation detection rates between urine and plasma cfDNA. RESULTS HBV transrenal DNA fragments from HCC patients were significantly shorter than those from patients with hepatitis or cirrhosis and displayed distinct 5’ 4-mer end motifs. Compared with plasma, urine samples contained higher levels of HCC-distinctive 5’ 4-mer end motifs. Mutation detection rates were comparable between urine and plasma, with urine higher mutation for TP53 in NGS. Among 101 HCC patients, detection of TP53 , CTNNB1 , and TERT mutations showed a 78.3% overall concordance between urine and plasma cfDNA. In a subset of 15 patients analyzed by HCC-targeted NGS, positional-level concordance between urine and plasma cfDNA reached 97%. CONCLUSION Urine cfDNA demonstrates both overlapping and unique features compared with plasma cfDNA, supporting its potential as a noninvasive and accessible source for genetic profiling of liver cancer.

Zitieren

APA

Kim, A. K., Lin, S. Y., Liu, H., Jain, S., Gade, T. P., Shieh, F., Hamilton, J., Hann, H., Chang, T., Goryunov, D., Wang, Z., & Su, Y. (2026). Urinary cell-free DNA as a noninvasive liquid biopsy for hepatocellular carcinoma. World Journal of Gastroenterology, 32(33). https://doi.org/10.3748/wjg.118587

Vancouver

Kim AK, Lin SY, Liu H, Jain S, Gade TP, Shieh F, et al. Urinary cell-free DNA as a noninvasive liquid biopsy for hepatocellular carcinoma. World Journal of Gastroenterology. 2026;32(33). doi:10.3748/wjg.118587

BibTeX
@article{Kim2026,
  author = {Kim, Amy K and Lin, Selena Y and Liu, Hsin-Ni and Jain, Surbhi and Gade, Terence P and Shieh, Fwu-Shan and Hamilton, James and Hann, Hie-Won and Chang, Ting-Tsung and Goryunov, Dmitry and Wang, Zhili and Su, Ying-Hsiu},
  title = {Urinary cell-free DNA as a noninvasive liquid biopsy for hepatocellular carcinoma},
  journal = {World Journal of Gastroenterology},
  year = {2026},
  volume = {32},
  number = {33},
  doi = {10.3748/wjg.118587}
}
Kostenlos starten →